Its role Investor / Financier
Chemelot Ventures B.V. is a Dutch venture capital firm focused on early-stage investments in materials science, life sciences, sustainable chemicals, and related technologies. Headquartered in Geleen, Limburg, it operates primarily within the Brightlands Chemelot Campus ecosystem, supporting innovative companies through capital, networks, and proximity to research and industry partners.
Established in 2014 as the successor to Limburg Ventures, the firm has invested in approximately 19 companies, targeting areas such as regenerative medicine, biomedical materials, diagnostics, analytics, and circular economy initiatives. Its limited partners include DSM Nederland, the Province of Limburg, regional development agency LIOF, and Rabobank, which enhance portfolio value through strategic connections and expertise in the south Netherlands region.
Chemelot Ventures typically deploys investments ranging from €250,000 to €8 million across seed, early, growth, and later stages. It emphasizes companies that align with the Brightlands campuses' strengths in chemicals, materials, and life sciences, often backing product companies, technology platforms, and sustainability-focused ventures. The firm is managed in connection with Brightlands Venture Partners (BVP) and maintains a 12-year fund life with a six-year investment period.
Registered as a B.V. under KVK number 59126493, Chemelot Ventures plays a key role in the regional innovation landscape by fostering startups that can accelerate time-to-market through ecosystem integration. It has participated in funding rounds for companies including Vertoro, a renewable oil technology developer.
Also known as Chemelot Ventures Management B.V..
chemXplore tracks 1 project involving Chemelot Ventures, of which one is active.
Raises €17m first-close to scale a low-pressure, catalyst-free process that converts plant waste into a modular renewable oil for chemicals, shipping and aviation.